FDA Import Refusal AEK-2201652-8/1/1 — Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation — FEI 2210396

The FDA refused shipment AEK-2201652-8/1/1 from Novartis Pharmaceuticals Corporation (United States) on August 3, 2016. The refused product falls under Drugs and Biologics — VALSARTAN (ANTI-HYPERTENSIVE - PART II). Cited charges: 118,16,75 This firm has 5 or more other import refusals on record.